1. |
Liu S, Lutz J, Chang J, et al. TRAF6 knockdown promotes survival and inhibits inflammatory response to lipopolysaccharides in rat primary renal proximal tubule cells[J]. Acta Physiol (Oxf), 2010, 199(3):339-346.
|
2. |
许国莹, 周红. 信号分子TRAF6的研究进展[J]. 细胞与分子免疫学杂志, 2010, 26(12):1326-1328.
|
3. |
Wu H, Arron JR. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology[J]. Bioessays, 2003, 25(11):1096-1105.
|
4. |
Karin M, Lin A. NF-kappaB at the crossroads of life and death[J]. Nat Immun, 2002, 3(3):221-227.
|
5. |
Xu LG, Li LY, Shu HB. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis[J]. J Biol Chem, 2004, 279(17):17278-17282.
|
6. |
Miyahara T, Koyama H, Miyata T, et al. Inflammatory signalingpathway containing TRAF6 contributes to neointimal formation via diverse mechanisms[J]. Cardiovasc Res, 2004, 64(1):154-164.
|
7. |
Kobayashi T, Walsh PT, Walsh MC, et al. TRAF6 is a critical factor for dendritic cell maturation and development[J]. Immunity,.
|
8. |
Cao Z, Xiong J, Takeuchi M, et al. TRAF6 is a signal transducer for interleukin-1[J]. Nature, 1996, 383(6599):443-446.
|
9. |
Greene C, O’neill L. Interleukin-1 receptor-associated kinase and TRAF-6 mediate the transcriptional regulation of interleukin-2 by interleukin-1 via NF-kappaB but unlike interleukin-1 are unable to stabilise interleukin-2 mRNA[J]. Biochim Biophys Acta, 1999, 1451(1):109-121.
|
10. |
Matsumura T, Degawa T, Takii T, et al. TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes[J]. Immunology, 2003, 109(1):127-136.
|
11. |
Kawai T, Akira S. Toll-like receptor downstream signaling[J]. Arthritis Res Ther, 2005, 7(1):12-19.
|
12. |
Xu J, Wu HF, Ang ES, et al. NF-kappaB modulators in osteolytic bone diseases[J]. Cytokine Growth Factor Rev, 2009, 20(1):7-17.
|
13. |
Lomaga MA, Henderson JT, Elia AJ, et al. Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS[J]. Neuroscience, 2000, 20(19):7384-7393.
|
14. |
McCarthy JV, Ni J, Dixit VM. RIP2 is a novel NF-kappa B-activating and cell-death-inducing kinase[J]. J Biol Chem, 1998, 273(27):16968-16975.
|
15. |
Bertin J, Nir WJ, Fischer CM, et al. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappa B[J]. J Biol Chem, 1999, 274(19):12955-12958.
|
16. |
He L, Wu X, Siegel R, et al. TRAF6 regulates cell fate decisionsby inducing caspase 8-dependent apoptosis and the activation of NF-kappaB[J]. J Biol Chem, 2006, 281(16):11235-11249.
|
17. |
Yoon K, Jung EJ, Lee SR, et al. TRAF6 deficiency promotes TNF-induced cell death through inactivation of GSK3beta[J]. Cell Death Differ, 2008, 15(4):730-738.
|
18. |
Yoon K, Jung EJ, Lee SY. TRAF6-mediated regulation of the PI3 kinase (PI3K)-Akt-GSK3beta cascade is required for TNF-induced cell survival[J]. Biochem Biophys Res Commun, 2008, 371(1):118-121.
|
19. |
Liu H, Tamashiro S, Baritaki S, et al. TRAF6 activation in multiple myeloma:a potential therapeutic target[J]. Clin Lymphoma Myeloma Leuk, 2012, 12(3):155-163.
|
20. |
Chen H, Li M, Campbell RA, et al. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferationand enhances apoptosis[J]. Oncogene, 2006, 25(49):6520-6527.
|
21. |
Meng Q, Zheng M, Liu H, et al. TRAF6 regulates proliferation,apoptosis, and invasion of osteosarcoma cell[J]. Mol Cell Biochem, 2012, 371(1-2):177-186.
|
22. |
Ma T, Wang N, Su Z, et al. Characterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6[J]. Mol Cell Biochem, 2011, 352(1-2):77-85.
|
23. |
Liu H, Zhang T, Ye J, et al. TNF receptor-associated factor 6 in advanced non-small cell lung cancer:clinical and prognostic impli-cations[J]. J Cancer Res Clin Oncol, 2012, 138(11):1853-1863.
|
24. |
Jundi M, Nadiri A, Al-Zoobi L, et al. CD40-mediated cell death requires TRAF6 recruitment[J]. Immunobiology, 2012, 217(3):375-383.
|
25. |
Elmetwali T, Young LS, Palmer DH. CD40 ligand-induced carci-noma cell death:a balance between activation of TNFR-associatedfactor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals[J]. J Immunol, 2010, 184(2):1111-1120.
|
26. |
Yeiser EC, Rutkoski NJ, Naito A, et al. Neurotrophin signaling through the p75 receptor is deficient in traf6-/- mice[J]. Neuroscience, 2004, 24(46):10521-10529.
|
27. |
Geetha T, Zheng C, Mcgregor WC, et al. TRAF6 and p62 inhibitamyloid β-induced neuronal death through p75 neurotrophin receptor[J]. Neurochem Int, 2012, 61(8):1289-1293.
|
28. |
Chen J, Wu X, Shao B, et al. Increased expression of TNF receptor-associated factor 6 after rat traumatic brain injury[J]. Cell Mol Neurobiol, 2011, 31(2):269-275.
|
29. |
Yuan P, Liu Z, Liu M, et al. Up-regulated tumor necrosis factor-associated factor 6 level is correlated with apoptosis in the rat cerebral ischemia and reperfusion[J]. Neurol Sci, 2012. [Epub ahead of print].
|
30. |
Wong F, Hull C, Zhande R, et al. Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal[J]. Blood, 2004, 103(12):4520-4526.
|
31. |
Hull C, Mclean G, Wong F, et al. Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase[J]. J Immunol, 2002, 169(5):2611-2618.
|
32. |
Bruneau S, Datta D, Flaxenburg JA, et al. TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor[J]. Biochem Biophys Res Commun, 2012, 419(1):66-71.
|
33. |
Zhou X, Li Y, Ding J, et al. Down-regulation of tumor necrosis factor-associated factor 6 is associated with progression of acute pancreatitis complicating lung injury in mice[J]. Tohoku J Exp Med, 2009, 217(4):279-285.
|
34. |
袁平, 周翔宇. TRAF6在机体炎症和免疫应答中作用的研究进展[J]. 现代免疫学, 2010, 30(3):262-265.
|
35. |
Yang YJ, Chen W, Carrigan SO, et al. TRAF6 specifically contri-butes to FcepsilonRI-mediated cytokine production but not mast cell degranulation[J]. J Biol Chem, 2008, 283(46):32110-32118.
|
36. |
, 19(3):353-363.
|